Animal models of IgA nephropathy: Formulating therapeutic strategies

Nephrology

Volumn 3, Issue 1, 1997, Pages 45-50

  Emancipator, Steven N ^a   Chintalacharuvu, Subba R ^a   Bagheri, Nayer ^a   Scivittaro, Vincenzo ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

glomerulonephritis; IgA nephropathy; mucosal immunity; pathophysiology

Indexed keywords

CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN A;

ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; CONFERENCE PAPER; DRUG DEVELOPMENT; GLOMERULONEPHRITIS; IMMUNITY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOGENESIS; KIDNEY BLOOD FLOW; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

EID: 0030935876     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00188.x     Document Type: Conference Paper

References (35)

1. Emancipator SN, Lamm ME. IgA Nephropathy and Related Diseases. In: Ogra PL, Strober W, Mestecky J, McGhee JR, Lamm ME, Bienenstock J (eds.) Handbook of Mucosal Immunology. Academic Press, San Diego, 1994; 663-76.
2. Emancipator SN, Ovary Z, Lamm ME. The role of mesangial complement in the hematuria of experimental IgA nephropathy. Lab. Invest. 1989; 60: 168-83.
3. Gesualdo L, Lamm ME, Emancipator SN. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J. Immunol. 1990; 145: 3684-91.
4. Scivittaro V, Rao CS, Clemens C, Emancipator SN. Effect of protracted oral immunization on lymphoid tissue cytokine production: ramifications for immunoregulation. J. Immunol. 1997 (in press).
5. Amore A, Coppo R, Nedrud J et al. Mucosal tolerance failure in an experimental model of IgA nephropathy in mice induced by Sendai virus. Kidney Int. (in press).
6. Harper SJ, Pringle JH, Wicks ACB et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int. 1994; 45: 836-44.
7. Harper SJ, Allen AC, Layward L et al. Increased immunoglobulin A and immunoglobulin A1 cells in hone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am. J. Kidney Dis. 1994; 24: 888-892.
8. Emancipator SN, Lamm ME. IgA nephropathy: overproduction or decreased clearance of immune complexes? Lab. Invest. 1989; 61: 365-7.
9. Sato M, Idewa T, Koshikowa S. Experimental IgA nephropathy in mice. Lab. Invest. 1986; 54: 377-84.
10. Amore A, Coppo R, Piccoli G et al. Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. Lab. Invest. 1994; 70: 68-77.
11. Amore A, Roccatello D, Picciotto G et. al. Liver processing of an aggregated immunoglobulin A test probe in a rat model of chronic liver disease. Clin. Exp. Immunol. 1997 (in press).
12. 1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 1995; 100: 470-4.
13. 1 hinge regions in IgA nephropathy. Fundamental study for precise structure and possible role. Contrib. Nephrol. 1995; 111: 73-84.
14. Wold AE, Motas C, Svanborg C et al. Characterization of IgA1, IgA2 and secretory IgA carbohydrate chains using plant lectins. Adv. Exp. Med. Biol. 1995; 371A: 585-89.
15. Tomana M, Julian BA, Waldo FB, Kulhavy R, Mestecky J. IgA nephropathy. A disease of incomplete IgA1 glycosylation? Adv. Exp. Med. Biol. 1995; 376: 221.
16. Rao CS, Emancipator SN. Interleukins 4 and 5 alter oligosaccharides on IgA in mice and humans: ramifications for kinetics of deposition and complement fixation. J. Am. Soc. Nephrol. 1994; 5: 771 (abstr.).
17. 1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 1993; 104: 172-82.
18. Amore A, Emancipator SN, Roccatello D et al. Functional consequences of the binding of gliadin to cultured rat mesagial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. Am. J. Kidney Dis. 1994; 23: 290-301.
19. Zhang W, Lachmann PJ. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology 1994; 81: 137-41.
20. Chintalacharuvu SR, Emancipator SN. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J. Exp. Med. 1997 (in press).
21. Scivittaro V, Gesualdo L, Ranieri E et al. Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred. Clin. Exp. Immunol. 1994; 96: 311-16.
22. Tykocinski ML, Kaplan DR, Medof ME. Antigen-presenting cell engineering. The molecular tool box. Am. J. Pathol. 1996; 148: 1-16.
23. Gesualdo L, Emancipator SN, Kesselheim C, Lamm ME. Glomerular hemodynamics and eicosanoid synthesis in a rar model of IgA nephropathy. Kidney Int. 1992; 42: 106-14.
24. Knauss TC, Mene P, Ricanati SA et al. Immune complex activation of rat glomerular mesangial cells: dependence on the Fc region of antibody. Am. J. Physiol. 1989; 257: F478-85.
25. Remuzzi A, Perticucci E, Ruggenenti P et al. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int. 1991; 39: 1267-73.
26. Coppo R, Amore A, Gianoglio B et al. Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am. J. Kidney Dis. 1993; 21: 593-603.
27. Emancipator SN, Sedor JR. Cytokines in renal disease. In: Kunkel SL, Remick DG (eds). Cytokines in Health and Disease. Marcel Dekker, Boston, 1992; 467-88.
28. Montinaro V, Hevey K, Aventaggiato L. Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int. 1992; 42: 341-53.
29. Chen A, Chen WP, Sheu LF, Lin CY. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complexes leads to cytokine secretion. J. Pathol. 1994; 173: 119-26.
30. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J. Soluble IgA and IgG aggregates are catabolized by cultured rat MC and induce production of TNF-α and IL-6, and proliferation. J. Immunol. 1994; 153: 5247-55.
31. van den Dobbelsteen MEQ, van der Woude FJ, Schroeijers WEM et al. Binding of dimeric and polymeric IgA to renal mesangial cells enhances the release of IL-6. Kidney Int. 1994; 46: 512-19.
32. Bagheri N, Chintalacharuvu SR, Emancipator SN. Proinflammatory cytokines regulate FcaR expression by human mesangial cells in vitro. Clin. Exp. Immunol. 1997 (in press).
33. Floege J, Eng E, Young BA, Johnson RJ. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int. 1993; 43: S47-S54.
34. Abboud HE. Growth factors in glomerulonephritis. Kidney Int. 1993; 43: 252-67.
35. Gesualdo L, Di Paolo S, Ranieri E, Schena FP. Growth factors and their receptors in the progression of renal damage. Contrib. Nephrol. 1995; 111: 38-44.